AlphaFold predicted structure
CAMK2A · Q9UQM7

Mean pLDDT
85.8/ 100
Confident
478 residues
Confidence breakdown
- Very high(≥ 90)62%
- Confident(70–90)25%
- Low(50–70)5%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
calcium/calmodulin dependent protein kinase II alpha
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownintellectual disability, autosomal dominant 53
Intellectual disability
intellectual disability, autosomal recessive 63
complex neurodevelopmental disorder
dengue disease
autosomal dominant non-syndromic intellectual disability
smoking initiation
inflammatory bowel disease
neurodegenerative disease
Global developmental delay
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Calcium/calmodulin-dependent protein kinase type II subunit alpha
Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in various processes, such as synaptic plasticity, neurotransmitter release and long-term potentiation (PubMed:14722083). Member of the NMDAR signaling complex in excitatory synapses, it regulates NMDAR-dependent potentiation of the AMPAR and therefore excitatory synaptic transmission (By similarity). Regulates dendritic spine development (PubMed:28130356). Also regulates the migration of developing neurons (PubMed:29100089). Phosphorylates the transcription factor FOXO3 to activate its transcriptional activity (PubMed:23805378). Phosphorylates the transcription factor ETS1 in response to calcium signaling, thereby decreasing ETS1 affinity for DNA (By similarity). In response to interferon-gamma (IFN-gamma) stimulation, catalyzes phosphorylation of STAT1, stimulating the JAK-STAT signaling pathway (PubMed:11972023). In response to interferon-beta (IFN-beta) stimulation, stimulates the JAK-STAT signaling pathway (PubMed:35568036). In response to interferon-gamma (IFN-gamma) stimulation, catalyzes phosphorylation of PSAT1, inhibiting ferroptosis by promoting GPX4 hydroxylation and stability (PubMed:40281343). Acts as a negative regulator of 2-arachidonoylglycerol (2-AG)-mediated synaptic signaling via modulation of DAGLA activity (By similarity)
CAMK2A · Q9UQM7

Mean pLDDT
85.8/ 100
Confident
478 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0